Don't miss out on Wednesday 6th November 2024, when MariMed (MRMD) will disclose its third quarter financial results after market close. Investors will have the chance to learn more about the company's performance during the quarter.
Based on the predictions of financial experts on Wall Street, the establishment is expected to reveal an anticipated $0.01 loss per share for the quarter. Additionally, the firm is poised to disclose a total revenue of $41.6 million for the quarter.
The company's yearly performance has been analyzed by Wall Street analysts, who have projected a total revenue of $162.95 million. Moreover, they anticipate the company to disclose loss of $0.02 per share for the fiscal year.
During the same quarter of the previous year, the company's earnings report indicated a per-share loss of $0.01. This noteworthy figure was a direct outcome of the company's total revenue, which reached an impressive $38.8 million during that specific period.
Throughout Friday's trading, MariMed (MRMD) shares fluctuated between $0.16 and $0.17, with a trading volume of 84.00 thousand shares. The stock ended the regular trading session at $0.16, showing of 0.00 percent.
